Vaxcyte News

Analysts Offer Insights on Healthcare Companies: Herbalife (HLF), Alignment Healthcare (ALHC) and Vaxcyte (PCVX)

TipRanksMay 17 08:40

Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Apogee Therapeutics, Inc. (APGE)

TipRanksMay 13 10:20

Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview

Yahoo FinanceMay 10 11:32

Is Vaxcyte (NASDAQ:PCVX) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi

Simply Wall StMay 10 08:43

Buy Rating Reaffirmed for Vaxcyte Amid Financial Discipline and Promising Vaccine Trials

TipRanksMay 10 00:28

Cantor Fitzgerald Reiterates Overweight on Vaxcyte

Cantor Fitzgerald analyst Louise Chen reiterates Vaxcyte (NASDAQ:PCVX) with a Overweight.

BenzingaMay 9 10:14

Buy Rating Affirmed for Vaxcyte Amid Promising Pipeline and Clear Milestones

TipRanksMay 9 05:46

Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target

Needham analyst Joseph Stringer reiterates Vaxcyte (NASDAQ:PCVX) with a Buy and maintains $95 price target.

BenzingaMay 9 05:43

Vaxcyte Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 42.24% Needham → $95 Reiterates Buy → Buy 04/10/2024 42.24% Needham → $95 Reiterates Buy → Buy

BenzingaMay 9 05:43

Vaxcyte Q1 EPS $(0.85) Beats $(1.09) Estimate

Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.09) by 22.02 percent. This is a 21.43 percent decrease over losses of $(0.70) per

BenzingaMay 8 16:26

Vaxcyte | 10-Q: Quarterly report

Futu NewsMay 8 15:19 · Announcements

Vaxcyte 1Q Loss/Shr 85c >PCVX

Vaxcyte 1Q Loss/Shr 85c >PCVX

Dow JonesMay 8 15:05

Press Release: Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update -- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected i

Dow JonesMay 8 15:05

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 ---- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyt

VaxcyteMay 7 23:00

Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares

Yahoo FinanceMay 4 01:31

Vaxcyte(PCVX.US) Officer Sells US$184.94K in Common Stock

$Vaxcyte(PCVX.US)$ Officer Wassil Jim sold 3,000 shares of common stock on May 1, 2024 at an average price of $61.647 for a total value of $184.94K.Source: Announcement What is statement of changes in

Futu NewsMay 3 16:05

Vaxcyte(PCVX.US) Officer Sells US$161.42K in Common Stock

$Vaxcyte(PCVX.US)$ Officer PICKERING GRANT sold 2,616 shares of common stock on May 1, 2024 at an average price of $61.705 for a total value of $161.42K.Source: Announcement What is statement of chang

Futu NewsMay 3 16:04

Vaxcyte(PCVX.US) Officer Sells US$102.92K in Common Stock

$Vaxcyte(PCVX.US)$ Officer Eydelman Mikhail sold 1,667 shares of common stock on May 1, 2024 at an average price of $61.74 for a total value of $102.92K.Source: Announcement What is statement of chang

Futu NewsMay 3 16:04

Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 182.28K in Common Stocks

SEC FILLINGS DISCLOSED/ May 1, $Vaxcyte(PCVX.US)$ Officer Wassil Jim intends to sell 3,000 shares of its common stock on May 1, with a total market value of approximately $182.28K. Wassil Jim has re

Futu NewsMay 1 15:09

Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 158.95K in Common Stocks

SEC FILLINGS DISCLOSED/ May 1, $Vaxcyte(PCVX.US)$ Officer PICKERING GRANT intends to sell 2,616 shares of its common stock on May 1, with a total market value of approximately $158.95K. PICKERING GR

Futu NewsMay 1 15:08